Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0003827 alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetically inferred core molecular function and exactly the experimentally established activity of MGAT1/GnT-I (EC 2.4.1.101). This is the specific, informative GlcNAc-TI term and is the core function of the gene.
GO:0006487 protein N-linked glycosylation	IBA GO_REF:0000033	ACCEPT	Summary: Correct core biological process. MGAT1 performs the committed step that converts oligomannose to hybrid/complex N-glycans during protein N-linked glycosylation. Concordant with the IDA annotation to the same term. Accept.
GO:0005794 Golgi apparatus	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetic inference of Golgi localization, consistent with the experimental IDA Golgi membrane annotation and with MGAT1 being a medial-Golgi glycosyltransferase. The more specific Golgi membrane term is preferable, but this organelle-level call is correct. Accept.
GO:0000139 Golgi membrane	IEA GO_REF:0000044	ACCEPT	Summary: Electronic mapping from the UniProt subcellular-location keyword (Golgi apparatus membrane). Same content as the experimental IDA Golgi membrane annotation; this is the core, correct subcellular location. Accept.
GO:0003827 alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity	IEA GO_REF:0000120	ACCEPT	Summary: Electronic prediction of the specific GlcNAc-TI activity. Identical in content to the IBA/IDA/EXP/TAS annotations to the same term and is the core function. Accept.
GO:0008375 acetylglucosaminyltransferase activity	IEA GO_REF:0000120	MODIFY	Summary: Correct but over-general parent of the specific GlcNAc-TI activity. The precise child term GO:0003827 (alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity) is experimentally supported and should be used instead. Proposed replacements: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
GO:0009101 glycoprotein biosynthetic process	IEA GO_REF:0000002	MODIFY	Summary: Over-general InterPro-derived process term. MGAT1 acts specifically in protein N-linked glycosylation (the oligomannose-to-complex committed step); the specific N-linked glycosylation term is more informative. Proposed replacements: protein N-linked glycosylation
GO:0048471 perinuclear region of cytoplasm	IEA GO_REF:0000044	KEEP AS NON CORE	Summary: Electronic mapping from the UniProt "Cytoplasm, perinuclear region" location, which derives from PMID:30983867 where MGAT1 co-localizes with BRI3 isoform 1 in the perinuclear area (consistent with the peri-Golgi position of a Golgi enzyme). This is a juxta-Golgi appearance rather than a distinct cytoplasmic compartment of MGAT1 function; keep as a plausible secondary location but not core. Supporting Evidence: PMID:30983867 intense colocalization of BRI3 with MGAT1, especially in the perinuclear area of Huh7 cells
GO:0005515 protein binding	IPI PMID:30983867 Identification of IFITM3 and MGAT1 as novel interaction part...	MARK AS OVER ANNOTATED	Summary: Generic "protein binding" from a yeast two-hybrid plus co-IP/colocalization interaction with BRI3 (ITM2C). Per curation guidelines this term is uninformative about molecular function, and the BRI3 interaction has no established link to MGAT1 catalytic activity or the N-glycosylation pathway (BRI3 is a poorly characterized lysosomal/TNF-pathway protein). Over-annotation; not a core function. Supporting Evidence: PMID:30983867 IFITM3 and MGAT1 proteins were confirmed as interaction partners by using cotransformation in yeast cells and coimmunoprecipitation from mammalian cell lines
GO:0003827 alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity	TAS Reactome:R-HSA-964768	ACCEPT	Summary: Reactome traceable annotation for the reaction "Addition of GlcNAc to the glycan on the A arm", described as the first committed step in complex/hybrid N-glycan synthesis. Exactly the core GlcNAc-TI activity. Accept. Supporting Evidence: Reactome:R-HSA-964768 This is the first committed step in the synthesis of complex and hybrid N-glycans
GO:0003827 alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity	EXP PMID:36280670 A universal glycoenzyme biosynthesis pipeline that enables e...	ACCEPT	Summary: Experimental support for the GlcNAc-TI activity. PMID:36280670 (Jaroentomeechai et al.) is a cell-free glycoenzyme pipeline in which MGAT1/GnT-I was produced as a water-soluble enzyme and used in N-glycan remodeling; UniProt cites it as ECO:0000269 evidence for MGAT1 catalytic activity. The abstract describes the general 98-glycosyltransferase platform rather than MGAT1 by name, but the curated experimental evidence supports the specific activity, which is in any case the well-established core function. Accept. Supporting Evidence: PMID:36280670 facile production of 98 difficult-to-express GTs, predominantly of human origin
GO:0019082 viral protein processing	TAS Reactome:R-HSA-9683686	KEEP AS NON CORE	Summary: Reactome annotation placing MGAT1 in SARS-CoV spike-protein maturation, where it performs its normal N-glycan branching on a viral glycoprotein substrate. This is the housekeeping GlcNAc-TI activity applied to a viral substrate rather than a dedicated antiviral/viral-processing function of MGAT1; keep but not core.
GO:0019082 viral protein processing	TAS Reactome:R-HSA-9694548	KEEP AS NON CORE	Summary: Duplicate Reactome "Maturation of spike protein" annotation (different stable ID). Same interpretation as the other viral protein processing annotation: substrate application of the normal Golgi N-glycan branching activity, not a core viral function.
GO:0008375 acetylglucosaminyltransferase activity	TAS Reactome:R-HSA-9683648	MODIFY	Summary: Reactome MF annotation from "Spike trimer glycoside chains are extended", which states GlcNAc-TI (MGAT1) adds a GlcNAc residue to high-mannose chains. Correct direction but over-general; the specific GlcNAc-TI term GO:0003827 captures the activity. Proposed replacements: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity Supporting Evidence: Reactome:R-HSA-9683648 The N-acetylglucosaminyltransferase called GlcNAc-TI (MGAT1) adds a GlcNAc residue in the core of some high-mannose chains
GO:0008375 acetylglucosaminyltransferase activity	TAS Reactome:R-HSA-9694656	MODIFY	Summary: Duplicate Reactome "Spike trimer glycoside chains are extended" MF annotation. Same over-general issue; replace with the specific GlcNAc-TI activity term. Proposed replacements: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane	TAS Reactome:R-HSA-964768	KEEP AS NON CORE	Summary: Reactome places the GlcNAc-TI reaction at the ERGIC membrane. The best-supported experimental location is the medial-Golgi membrane (IDA, PMID:20378551); an ERGIC pool is biologically plausible for an early secretory-pathway glycosyltransferase but is secondary to the Golgi location. Keep as non-core.
GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane	TAS Reactome:R-HSA-9683648	KEEP AS NON CORE	Summary: Duplicate ERGIC-membrane location from the viral spike Reactome reaction. Same interpretation: plausible secondary secretory-pathway location, secondary to the experimentally supported Golgi membrane. Keep as non-core.
GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane	TAS Reactome:R-HSA-9694656	KEEP AS NON CORE	Summary: Duplicate ERGIC-membrane location (third Reactome stable ID). Keep as a plausible secondary location; the core compartment is the Golgi membrane.
GO:0000139 Golgi membrane	IDA PMID:20378551 Golgi N-glycosyltransferases form both homo- and heterodimer...	ACCEPT	Summary: Direct experimental localization: live-cell bimolecular fluorescence complementation showed MGAT1 (GnTI) forms Golgi-localized homodimers and a medial-Golgi heterodimer with MGAT2 (GnTII), with signal detected only in the Golgi membranes. This is the core, experimentally supported subcellular location. Accept. Supporting Evidence: PMID:20378551 the BiFC signal with GnTI was detected only in the Golgi membranes of live cells
GO:0003827 alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity	IDA PMID:1702225 Cloning and expression of N-acetylglucosaminyltransferase I,...	ACCEPT	Summary: Foundational direct experimental support: the human gene was identified by complementation of the N-glycosylation defect of the Lec1 CHO mutant, and the cloned cDNA confers GlcNAc-TI (EC 2.4.1.101) activity. This is the defining core molecular function of MGAT1. Accept. Supporting Evidence: PMID:1702225 full-length cDNA encoding human GlcNAc-TI activity
GO:0006487 protein N-linked glycosylation	IDA PMID:1702225 Cloning and expression of N-acetylglucosaminyltransferase I,...	ACCEPT	Summary: Direct experimental support for involvement in protein N-linked glycosylation: MGAT1 is "the medial Golgi transferase that initiates complex N-linked carbohydrate formation". Core biological process. Accept. Supporting Evidence: PMID:1702225 the medial Golgi transferase that initiates complex N-linked carbohydrate formation
GO:0030145 manganese ion binding	IDA PMID:1702225 Cloning and expression of N-acetylglucosaminyltransferase I,...	ACCEPT	Summary: MGAT1/GnT-I is a Mn2+-dependent glycosyltransferase (UniProt COFACTOR: Mn2+; GT-A-type metal coordination of the UDP-GlcNAc donor). Manganese ion binding is a genuine, experimentally supported cofactor-binding molecular function and a core enzymatic property. Accept.
GO:1903561 extracellular vesicle	HDA PMID:24769233 Proteomic analysis of cerebrospinal fluid extracellular vesi...	MARK AS OVER ANNOTATED	Summary: High-throughput proteomic detection in cerebrospinal-fluid extracellular vesicles. MGAT1 is a Golgi-resident type II membrane enzyme; its presence in a vesicle proteome reflects secretory-pathway/membrane carryover rather than a functional extracellular-vesicle localization. Over-annotation.
GO:0070062 extracellular exosome	HDA PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres...	MARK AS OVER ANNOTATED	Summary: High-throughput exosome proteomics (expressed prostatic secretions). As with the other vesicle proteomics hits, this is bulk-MS detection in an exosome preparation, not evidence that MGAT1 functions in exosomes; it contradicts the well-established Golgi membrane location. Over-annotation.
GO:0016020 membrane	HDA PMID:19946888 Defining the membrane proteome of NK cells.	MARK AS OVER ANNOTATED	Summary: Trivial location from an NK-cell membrane-proteome MS dataset. MGAT1 is a single-pass membrane protein, so "membrane" is correct but uninformative; the specific Golgi membrane term supersedes it.
GO:0070062 extracellular exosome	HDA PMID:19199708 Proteomic analysis of human parotid gland exosomes by multid...	MARK AS OVER ANNOTATED	Summary: High-throughput parotid-gland exosome proteomics. Same interpretation as the other exosome HDA annotation: secretory-pathway carryover detected by bulk MS, not a functional exosomal location. Over-annotation.

Core Functions

MGAT1 catalyzes the first committed (gatekeeper) step of complex and hybrid N-glycan biosynthesis: as a Mn2+-dependent, UDP-GlcNAc-using type II Golgi membrane glycosyltransferase (GT13, EC 2.4.1.101), it transfers a single GlcNAc in beta-1,2 linkage onto the alpha-1,3-mannose arm of the protein-linked Man5GlcNAc2 N-glycan, generating the obligate substrate for downstream alpha-mannosidase II trimming and MGAT2/4/5 branching. This activity occurs in the medial Golgi and converts oligomannose N-glycans into hybrid and complex N-glycans; its loss (e.g. the Lec1 CHO mutant) abolishes all complex N-glycan synthesis.

Molecular Function:

alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity

Directly Involved In:

protein N-linked glycosylation

Cellular Locations:

Golgi membrane

Substrates:

UDP-N-acetyl-alpha-D-glucosamine

Supporting Evidence:

PMID:1702225
the medial Golgi transferase that initiates complex N-linked carbohydrate formation
Reactome:R-HSA-964768
This is the first committed step in the synthesis of complex and hybrid N-glycans
PMID:20378551
the BiFC signal with GnTI was detected only in the Golgi membranes of live cells

MGAT1 binds a divalent manganese ion as an essential catalytic cofactor; the Mn2+ coordinates the UDP-GlcNAc donor in the GT-A-type active site, and chelation abolishes GlcNAc-TI activity.

Molecular Function:

manganese ion binding

Cellular Locations:

Golgi membrane

Supporting Evidence:

PMID:1702225
full-length cDNA encoding human GlcNAc-TI activity

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:1702225

Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation.

The human MGAT1 gene was identified by complementation of the N-glycosylation defect of the Lec1 CHO mutant, and the cloned full-length cDNA encodes an active GlcNAc-TI (EC 2.4.1.101); the 445-aa protein is a type II Golgi transferase.

"full-length cDNA encoding human GlcNAc-TI activity. The overall features of the cDNA and deduced protein sequence (445 amino acids) are typical of other Golgi transferases that are type II transmembrane proteins."

PMID:20378551

Golgi N-glycosyltransferases form both homo- and heterodimeric enzyme complexes in live cells.

Live-cell BiFC shows MGAT1 (GnTI) forms Golgi-localized homodimers and a functionally relevant medial-Golgi heterodimer with MGAT2 (GnTII); BiFC signal was detected only in the Golgi membranes.

"the BiFC signal with GnTI was detected only in the Golgi membranes of live cells"

PMID:36280670

A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans.

A SIMPLEx-based platform produced ~98 difficult-to-express glycosyltransferases (predominantly human) as water-soluble, catalytically active enzymes for cell-free glycan remodeling, including complex-type N-glycan synthesis; UniProt cites this work as experimental evidence for MGAT1 catalytic activity.

"facile production of 98 difficult-to-express GTs, predominantly of human origin"

PMID:30983867

Identification of IFITM3 and MGAT1 as novel interaction partners of BRI3 by yeast two-hybrid screening.

MGAT1 was identified and confirmed (Y2H, co-IP, confocal colocalization) as an interaction partner of BRI3 (stronger with BRI3 isoform a/1), colocalizing in the perinuclear region.

"intense colocalization of BRI3 with MGAT1, especially in the perinuclear area of Huh7 cells"

PMID:24769233

Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.

PMID:23533145

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

PMID:19946888

Defining the membrane proteome of NK cells.

PMID:19199708

Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).

Reactome:R-HSA-964768

Addition of GlcNAc to the glycan on the A arm

Reactome reaction for the MGAT1-catalyzed first committed step in complex and hybrid N-glycan synthesis, modeled at the ER-Golgi intermediate compartment / Golgi membrane.

"This is the first committed step in the synthesis of complex and hybrid N-glycans"

Reactome:R-HSA-9683648

Spike trimer glycoside chains are extended

Reactome reaction in which GlcNAc-TI (MGAT1) adds a GlcNAc residue to high-mannose chains of the SARS-CoV spike glycoprotein during its N-glycan maturation.

"The N-acetylglucosaminyltransferase called GlcNAc-TI (MGAT1) adds a GlcNAc residue in the core of some high-mannose chains"

Reactome:R-HSA-9683686

Maturation of spike protein

Reactome:R-HSA-9694548

Maturation of spike protein

Reactome:R-HSA-9694656

Spike trimer glycoside chains are extended

file:human/MGAT1/MGAT1-deep-research-falcon.md

FutureHouse Falcon deep-research report for MGAT1

Deep-research synthesis: MGAT1/GnT-I is a Golgi type II GT13 glycosyltransferase that catalyzes the first committed step of complex/hybrid N-glycan synthesis (UDP-GlcNAc to alpha-1,3-Man arm of Man5GlcNAc2; Mn2+-dependent); its many developmental/immune/cancer phenotypes are indirect, substrate-mediated consequences of altered N-glycans and should not be annotated as direct MGAT1 functions.

"A key annotation risk is conflating the pleiotropic consequences of altered N-glycan structures on substrate glycoproteins with direct MGAT1 molecular activities."

Suggested Experiments

Experiment: Quantitative glycomic/glycoproteomic comparison of MGAT1-knockout versus wild-type human cells (mass spectrometry of released N-glycans) to confirm the expected complete loss of hybrid/complex N-glycans and accumulation of Man5GlcNAc2, recapitulating the Lec1 phenotype in a human background.

Experiment: In vitro reconstitution of purified human MGAT1 with defined Man5GlcNAc2 glycopeptide acceptors and UDP-GlcNAc to measure kinetics, strict Mn2+ dependence (EDTA sensitivity), and arm specificity (alpha-1,3 vs alpha-1,6), establishing direct human enzymology rather than relying on ortholog data.

Experiment: Tagged-MGAT1 co-localization and proximity-labeling (e.g. APEX/BioID) in live cells to map its medial-Golgi multi-enzyme assemblies (with MGAT2, MAN2A2, and UDP-GlcNAc transporters) and to test whether the perinuclear/ERGIC pools are catalytically engaged.

Deep Research

Falcon

(MGAT1-deep-research-falcon.md)

Gene Research for GO Annotation Review Falcon

Gene Research for GO Annotation Review

Target

Gene symbol: MGAT1
Organism: Homo sapiens

UniProt Context

=== UNIPROT METADATA ===
UniProt ID: P26572
Entry Name: MGAT1_HUMAN
Gene Name: MGAT1
Protein Name: Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
EC Number: 2.4.1.101
Organism: Homo sapiens (Human)
NCBI Taxonomy ID: 9606
Function: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans.
Subcellular Location: Golgi apparatus membrane
Subunit: Interacts with MGAT4D. Interacts with BRI3 (isoforms 1 and 2); the interaction with isoform 2 is weaker than with isoform 1 (PubMed:30983867).
======================

Research Objective

Prepare a comprehensive literature-backed research report for GO annotation review of the target gene.

Focus on:

The core biochemical activity of the gene product and any substrate specificity.
The activation or maturation mechanism of the protein, including proteolytic processing if relevant.
The best-supported subcellular localization and complexes where the active protein functions.
The strongest experimentally supported biological processes in the target organism, or in very close orthologs when transfer is justified.
Which annotations appear to reflect core function versus context-specific, pleiotropic, or over-extended roles.
Any evidence bearing on apoptosis, developmental cell death, neuronal roles, inflammatory signaling, pyroptosis, synaptic remodeling, protein processing, and localization to cytoplasm, cytosol, nucleus, or signaling complexes.

Output Requirements

Structure the report as:

Executive summary
Molecular function
Biological process roles
Cellular localization and complexes
Annotation-risk assessment
Key literature

Use citations for all substantive claims.

Comprehensive Literature-Backed Research Report for GO Annotation Review of MGAT1

Gene: MGAT1 (Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase)
Organism: Homo sapiens
UniProt ID: P26572
EC Number: 2.4.1.101

1. EXECUTIVE SUMMARY

MGAT1 (also known as GnT-I, GlcNAc-transferase I) encodes the glycosyltransferase that catalyzes the first committed step in the conversion of oligomannose N-glycans to hybrid and complex N-glycans (kizuka2024regulationofintracellular pages 1-2, abdelbary2023nlinkedglycansan pages 1-2). The enzyme transfers N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to the α-1,3-mannose arm of Man5GlcNAc2, forming a β-1,2-glycosidic linkage that is essential for all downstream hybrid and complex N-glycan biosynthesis (liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2). MGAT1 is a type II transmembrane protein localized to the medial-Golgi apparatus membrane, where it participates in multi-enzyme complexes with other glycosyltransferases and nucleotide sugar transporters (kizuka2024regulationofintracellular pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2).

The core function of MGAT1 is highly conserved and well-defined: protein N-glycosylation in the Golgi. Loss-of-function studies in mice demonstrate that Mgat1 deletion is embryonically lethal (E9.5-E10.5) due to neural tube maldevelopment, establishing MGAT1 as essential for early mammalian development (liu2026iterativebumpandholeengineering pages 1-4, hall2023reductioninnacetylglucosaminyltransferasei pages 1-2). MGAT1-dependent N-glycan maturation also plays critical roles in T-cell development, including β-selection, regulatory T-cell generation, and γδ T-cell lineage determination (abdelbary2023nlinkedglycansan pages 1-2, vicente2023mannosylatedglycansimpair pages 1-2).

Recent studies (2023-2025) have expanded understanding of MGAT1's context-specific roles in immune regulation, cancer progression, and metabolic processes, but these represent indirect, substrate-mediated effects rather than direct MGAT1 functions (chi2025mgat1guidedcomplexnglycans pages 1-2, zhou2024lactatesupportstreg pages 1-2, blomberg2025mgat1knockoutin pages 1-2). A key annotation risk is conflating the pleiotropic consequences of altered N-glycan structures on substrate glycoproteins with direct MGAT1 molecular activities.

2. MOLECULAR FUNCTION

2.1 Core Biochemical Activity

Aspect	MGAT1 finding	Evidence / notes
Enzyme name	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; also GnT-I / GlcNAc-transferase I	Identified as the key branching enzyme that initiates hybrid and complex N-glycan synthesis (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2)
Enzyme class	Glycosyltransferase; UDP-GlcNAc:α-1,3-D-mannoside β-1,2-N-acetylglucosaminyltransferase I	Explicitly described as transferring GlcNAc from UDP-GlcNAc to an α1,3-linked mannose acceptor (thoma2024determinationexpressionand pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2)
EC number	EC 2.4.1.101	Reported for GnT-I/MGAT1 in biochemical characterization and standard nomenclature (thoma2024determinationexpressionand pages 1-2)
Core biochemical activity	Catalyzes the first committed GlcNAc-branching step that converts high-mannose/oligomannose N-glycans into substrates for hybrid and complex N-glycan biosynthesis	MGAT1 is described as necessary to start elaboration of all hybrid and complex N-glycans and to initiate conversion from Man5 structures (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, abdelbary2023nlinkedglycansan pages 1-2, hall2023reductioninnacetylglucosaminyltransferasei pages 1-2)
Catalytic reaction	Transfers N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to the α1,3-Man arm of Man5GlcNAc2, creating a β1,2 linkage	Described as formation of a β-1,2-glycosidic bond between GlcNAc and a mannose on the α-1,3 arm of Man5GlcNAc2-Asn / Man5GlcNAc2 (liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Donor substrate	UDP-N-acetylglucosamine (UDP-GlcNAc)	Explicit donor substrate in MGAT1/GnT-I reactions (liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Acceptor substrate	Primarily Man5GlcNAc2 on N-glycoproteins; specifically the α1,3 mannose arm in the N-glycan core	Multiple sources define Man5GlcNAc2 as the physiologic substrate and the α1,3-Man arm as the acceptor site (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Product	GlcNAcβ1-2Manα1-3-containing intermediate that becomes substrate for MAN2A1/MAN2A2 and then MGAT2, enabling hybrid/complex N-glycan formation	Product is the entry point to downstream elaboration by α-mannosidase II and additional transferases (kizuka2024regulationofintracellular pages 1-2, abdelbary2023nlinkedglycansan pages 1-2, thoma2024determinationexpressionand pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Biosynthetic position	Acts after Golgi mannose trimming to a Man5 structure and before MAN2A1/MAN2A2 and MGAT2	Reviews and pathway diagrams place MGAT1 immediately before α-mannosidase II and MGAT2 in medial-Golgi N-glycan maturation (kizuka2024regulationofintracellular pages 1-2, abdelbary2023nlinkedglycansan pages 1-2, liu2024abioorthogonalprecision pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Functional consequence of reaction	Produces the obligatory substrate pool for downstream branching, extension, galactosylation, fucosylation, and terminal maturation of complex N-glycans	Loss of MGAT1 abolishes hybrid/complex N-glycan synthesis and leaves oligomannose-rich glycans (abdelbary2023nlinkedglycansan pages 1-2, blomberg2025mgat1knockoutin pages 1-2, hall2023reductioninnacetylglucosaminyltransferasei pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2)
Cofactor requirement	Divalent metal ions are required; Mn2+ is the key activating cofactor for GnT-I activity	Biochemical characterization of GnT-I orthologs shows divalent cations are indispensable, with highest activity at 40 mM Mn2+ and loss of activity with EDTA; reviews note Golgi glycosyltransferases commonly require Mn2+ (thoma2024determinationexpressionand pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Inhibitory metal/chelating conditions	EDTA abolishes activity; Cu2+ abolishes activity in ortholog biochemical assays	Supports metal dependence of GnT-I catalysis and risk of inferring activity in metal-poor conditions (thoma2024determinationexpressionand pages 1-2)
pH / temperature preference	Ortholog biochemical data: highest activity at pH 7.0 and 30°C using Man5 substrate	Direct human enzymology is not provided in retrieved texts, but the ortholog assay supports conserved catalytic preferences (thoma2024determinationexpressionand pages 1-2)
Donor specificity	Physiologic donor is UDP-GlcNAc; engineered studies show WT related MGAT enzymes can display some analog tolerance, but native MGAT1 function is defined by UDP-GlcNAc use	Recent bioorthogonal engineering work frames MGAT1 as a UDP-GlcNAc-dependent transferase and seeks variants that lose native donor use while accepting analogs, underscoring native donor specificity (liu2026iterativebumpandholeengineering pages 1-4, liu2024abioorthogonalprecision pages 1-2)
Acceptor specificity	Strong preference for the trimmed pentamannosyl N-glycan precursor rather than later complex products; recognizes a defined N-glycan arm rather than generic mannose residues	MGAT1 is repeatedly described as acting on Man5GlcNAc2 and specifically on the α1,3 arm, indicating narrow pathway position and acceptor selectivity (liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Site specificity within glycan	Adds GlcNAc to C-2 of the α1,3-linked core mannose	Explicitly stated in pathway descriptions of MGAT1 action (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Substrate context	Acceptors are N-glycans attached to glycoproteins traversing the secretory pathway; the reaction occurs on luminal glycan chains rather than free cytosolic glycans	MGAT1 catalytic activity is described in the Golgi lumen on glycoprotein N-glycans (liu2026iterativebumpandholeengineering pages 1-4, huang2015gnt1iplspecificallyinhibits pages 1-2)
Consequence of loss of function	Abolishes synthesis of hybrid and complex N-glycans and enriches oligomannose/high-mannose structures	Demonstrated in knockout/knockdown systems in dendritic cells, thymocytes, and zebrafish (vicente2023mannosylatedglycansimpair pages 1-2, blomberg2025mgat1knockoutin pages 1-2, hall2023reductioninnacetylglucosaminyltransferasei pages 1-2)
Protein type	Type II transmembrane Golgi glycoprotein	Multiple reviews and studies describe MGAT1/Golgi glycosyltransferases as type II membrane proteins (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2)
Domain organization	Short N-terminal cytosolic tail, single transmembrane domain, stem region, and large C-terminal luminal catalytic domain	Canonical architecture for MGAT1 and other Golgi glycosyltransferases is explicitly described (kizuka2024regulationofintracellular pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2)
Membrane topology	N-terminus faces cytosol; catalytic ectodomain faces the Golgi lumen	Follows type II membrane topology and is necessary for luminal access to UDP-GlcNAc and glycoprotein acceptors (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Subcellular localization relevant to function	Golgi apparatus membrane, especially cis/medial-Golgi or medial-Golgi during early branching steps	MGAT1 is consistently placed in the Golgi, particularly where Man5 glycans are processed into hybrid/complex forms (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, huang2015gnt1iplspecificallyinhibits pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)
Structural/catalytic architecture	Active-site-containing luminal catalytic domain plus additional glycan-recognition determinants/exosites inferred from GnT family structural studies; substrate recognition is highly pathway-ordered	Review literature notes crystal structures of rabbit GnT-I and exosite-based substrate recognition principles for N-glycan branching enzymes, supporting modular recognition beyond the catalytic center alone (biswas2020promiscuityandspecificity pages 1-2, liu2024abioorthogonalprecision pages 1-2)
Complexes influencing function	Can participate in Golgi multi-enzyme / multi-transporter assemblies with MAN2A2 and other MGATs, and with the UDP-GlcNAc transporter SLC35A3; can be inhibited by MGAT4D/GnT1IP-L in the Golgi	These interactions are relevant to efficient substrate channeling/regulation but do not alter the core catalytic definition of MGAT1 (huang2015gnt1iplspecificallyinhibits pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2)

Table: This table summarizes MGAT1’s core enzymatic function, donor and acceptor specificity, cofactor dependence, and structural organization for GO annotation review. It focuses on direct biochemical evidence and distinguishes core catalytic properties from regulatory interaction context.

MGAT1 functions as a UDP-N-acetylglucosamine:α-1,3-D-mannoside β-1,2-N-acetylglucosaminyltransferase (EC 2.4.1.101) (thoma2024determinationexpressionand pages 1-2). The enzyme catalyzes the transfer of N-acetylglucosamine from the donor substrate UDP-GlcNAc to the C-2 position of the α-1,3-linked mannose residue in the acceptor substrate Man5GlcNAc2 (liu2026iterativebumpandholeengineering pages 1-4, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2). This reaction produces the first branch point that distinguishes oligomannose from hybrid/complex N-glycans and creates the obligatory intermediate for all subsequent branching by MGAT2, MGAT4, and MGAT5 (kizuka2024regulationofintracellular pages 1-2, abdelbary2023nlinkedglycansan pages 1-2).

Recent bioorthogonal engineering studies confirm that while MGAT1 can display some promiscuity toward modified UDP-GlcNAc analogs, the native physiological donor is strictly UDP-GlcNAc (liu2026iterativebumpandholeengineering pages 1-4, liu2024abioorthogonalprecision pages 1-2). The acceptor specificity is highly pathway-ordered: MGAT1 efficiently acts on the pentamannosyl precursor (Man5GlcNAc2) following prior trimming by Golgi mannosidases, but shows minimal activity toward later complex products or other mannose-containing structures (biswas2020promiscuityandspecificity pages 1-2, thoma2024determinationexpressionand pages 1-2).

2.2 Cofactor Requirements and Catalytic Mechanism

MGAT1 requires divalent metal ions for catalytic activity, with Mn²⁺ serving as the principal cofactor (thoma2024determinationexpressionand pages 1-2). Biochemical characterization of GnT-I orthologs demonstrates that enzyme activity is completely abolished by EDTA chelation or Cu²⁺ addition, while optimal activity occurs at approximately 40 mM Mn²⁺ concentration (thoma2024determinationexpressionand pages 1-2). The pH optimum is near physiological conditions (pH 7.0), consistent with Golgi luminal function (thoma2024determinationexpressionand pages 1-2).

Crystal structure analyses of rabbit GnT-I and related family members reveal a modular catalytic architecture with distinct donor and acceptor binding sites, including exosites that recognize specific N-glycan structural motifs beyond the immediate reaction center (biswas2020promiscuityandspecificity pages 1-2, liu2024abioorthogonalprecision pages 1-2). The catalytic domain adopts a GT-A fold typical of many glycosyltransferases and uses metal coordination to stabilize the UDP-GlcNAc donor during nucleophilic attack (kizuka2024regulationofintracellular pages 1-2).

2.3 Substrate Specificity

The strict substrate specificity of MGAT1 is central to its role as a biosynthetic gatekeeper. The enzyme recognizes Man5GlcNAc2 attached to asparagine residues within glycoproteins trafficking through the secretory pathway (liu2026iterativebumpandholeengineering pages 1-4, thoma2024determinationexpressionand pages 1-2). Importantly, MGAT1 does not act on free oligosaccharides or cytosolic substrates; the reaction occurs exclusively on luminal glycan chains of Golgi-resident or transiting glycoproteins (kizuka2024regulationofintracellular pages 1-2, huang2015gnt1iplspecificallyinhibits pages 1-2).

Structural and mutational studies indicate that MGAT1 makes specific contacts with the trimannosyl core and the α-1,3-mannose arm, positioning it to selectively modify this arm while excluding the α-1,6-mannose arm (which becomes a substrate for MGAT2 only after MGAT1 action and subsequent mannosidase II trimming) (biswas2020promiscuityandspecificity pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2). This ordered specificity ensures proper N-glycan maturation along the biosynthetic pathway.

3. BIOLOGICAL PROCESS ROLES

3.1 Core Biological Process: Protein N-Glycosylation

The primary and universally conserved biological process annotation for MGAT1 is protein N-linked glycosylation, specifically the conversion of oligomannose to hybrid and complex N-glycans (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, abdelbary2023nlinkedglycansan pages 1-2). MGAT1 initiates the biosynthesis of all complex-type and hybrid-type N-glycans by adding the first GlcNAc branch to the pentamannosyl core (kizuka2024regulationofintracellular pages 1-2). This function is absolutely required for complex N-glycan formation, as demonstrated by MGAT1 knockout systems that accumulate only oligomannose structures and completely lack hybrid/complex glycans (vicente2023mannosylatedglycansimpair pages 1-2, blomberg2025mgat1knockoutin pages 1-2, hall2023reductioninnacetylglucosaminyltransferasei pages 1-2).

3.2 Well-Supported Developmental and Physiological Processes

Embryonic Development and Neural Tube Formation:
Loss of Mgat1 in mice causes embryonic lethality between E9.5 and E10.5, with severe neural tube maldevelopment being the primary cause of death (liu2026iterativebumpandholeengineering pages 1-4, hall2023reductioninnacetylglucosaminyltransferasei pages 1-2). This phenotype reflects the essential requirement for complex N-glycan structures on multiple developmental glycoproteins rather than a specific developmental signaling function of MGAT1 itself. In zebrafish models, reduced Mgat1 activity decreases survivability, delays brain anlagen formation, impairs skeletal muscle development, and disrupts cardiac activity onset (hall2023reductioninnacetylglucosaminyltransferasei pages 1-2).

T-Cell Development and Immune Cell Maturation:
Conditional deletion of Mgat1 in mouse thymocytes, which restricts N-glycosylation to high-mannose structures, causes profound defects in β-selection at the DN3-to-DN4 transition, impaired regulatory T-cell (Treg) generation, and altered γδ T-cell development (vicente2023mannosylatedglycansimpair pages 1-2). These phenotypes are associated with increased susceptibility to colon and kidney inflammation, demonstrating that MGAT1-dependent N-glycan maturation is critical for establishing proper immune homeostasis (vicente2023mannosylatedglycansimpair pages 1-2). However, these effects are mediated through altered glycosylation of T-cell receptors and coreceptors, not through direct participation of MGAT1 in TCR signaling or inflammation pathways.

Similarly, MGAT1 knockout in human dendritic cells enhances their capacity to activate CD8⁺ T cells by altering surface densities of costimulatory molecules and MHC complexes (blomberg2025mgat1knockoutin pages 1-2). This finding supports annotation to immune cell development and maturation processes, but emphasizes that MGAT1 acts indirectly by modulating the glycosylation state of immune receptors.

Spermatogenesis:
MGAT1 regulatory partner MGAT4D (GnT1IP) is highly expressed in spermatocytes and spermatids, and conditional deletion of Mgat2 in mouse germ cells blocks spermatogenesis, indicating overlapping requirements for N-glycan branching in male fertility (huang2015gnt1iplspecificallyinhibits pages 1-2). While direct human MGAT1-specific spermatogenesis evidence is limited in the retrieved literature, orthologous mammalian data support a conserved role in germ cell glycoprotein maturation.

3.3 Context-Specific and Substrate-Mediated Processes

Recent studies (2023-2025) have identified several MGAT1-associated processes that reflect context-specific, substrate-dependent phenomena rather than core MGAT1 functions:

Cancer Progression and Immune Evasion:
In triple-negative breast cancer (TNBC), MGAT1 overexpression drives complex N-glycosylation of CD73, promoting its membrane translocation via VAMP3-mediated fusion and enabling adenosine-dependent suppression of CD8⁺ T cell function (chi2025mgat1guidedcomplexnglycans pages 1-2). This represents a substrate-specific mechanism where MGAT1 indirectly promotes immune evasion by modifying a particular immunosuppressive ectoenzyme. Similar substrate-specific effects have been reported for other glycoproteins in various cancers (chi2025mgat1guidedcomplexnglycans pages 1-2, tang2023transcriptomicandglycomic pages 1-2). These findings should not lead to direct GO annotations of MGAT1 to "immune evasion" or "cancer progression," as the enzyme itself does not possess intrinsic oncogenic or immunosuppressive activity—it is the altered glycosylation of specific substrates in specific cellular contexts that drives these phenotypes.

Metabolic Regulation in Regulatory T Cells:
A notable 2024 study reports that lactate treatment of human Tregs increases MGAT1 expression and proposes that MGAT1 translocates to mitochondria, where it modulates oxidative phosphorylation through N-glycosylation of mitochondrial proteins such as progranulin (GRN) and HYOU1 (zhou2024lactatesupportstreg pages 1-2). This finding is mechanistically provocative but represents an emerging, context-specific observation that contrasts sharply with the well-established Golgi-resident model of MGAT1 (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, huang2015gnt1iplspecificallyinhibits pages 1-2). Independent validation is needed before this mitochondrial role is incorporated into core GO annotations.

Neuronal Function and Alzheimer's Disease:
Transcriptomic analysis of Alzheimer's disease (AD) brain tissue shows upregulation of MGAT1 and corresponding increases in complex N-glycan abundance (tang2023transcriptomicandglycomic pages 1-2). While this implicates MGAT1-dependent glycosylation in AD pathophysiology, it does not establish MGAT1 as a direct mediator of neurodegeneration or apoptosis. Previous literature cited in AD studies mentions associations between MGAT1 defects and neuronal apoptosis (tang2023transcriptomicandglycomic pages 1-2), but these are secondary consequences of failed glycoprotein maturation rather than evidence for direct apoptotic functions.

Inflammatory Responses:
Mgat1-deficient thymocytes show increased susceptibility to inflammatory conditions in mouse models (vicente2023mannosylatedglycansimpair pages 1-2). However, this phenotype arises from defective T-cell development and altered immune receptor glycosylation, not from direct MGAT1 participation in inflammatory signaling cascades. Annotation to broad inflammatory response terms should be avoided unless there is evidence of direct MGAT1 involvement beyond its glycosyltransferase activity.

4. CELLULAR LOCALIZATION AND COMPLEXES

4.1 Subcellular Localization

MGAT1 is a type II transmembrane protein localized to the Golgi apparatus membrane, specifically the medial-Golgi compartment where early N-glycan branching occurs (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, huang2015gnt1iplspecificallyinhibits pages 1-2). The protein has a short N-terminal cytosolic tail, a single-pass transmembrane domain, a stem region, and a large C-terminal catalytic domain that faces the Golgi lumen (kizuka2024regulationofintracellular pages 1-2, thoma2024determinationexpressionand pages 1-2). This topology allows MGAT1 to access both the UDP-GlcNAc donor (delivered by luminal nucleotide sugar transporters) and the glycoprotein acceptors traversing the secretory pathway (huang2015gnt1iplspecificallyinhibits pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2).

MGAT1 retention in the Golgi is mediated by multiple factors, including transmembrane domain length, stem region interactions, and oligomerization with other Golgi-resident enzymes (kizuka2024regulationofintracellular pages 1-2, khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2). The enzyme does not constitutively localize to the cytoplasm, cytosol, or nucleus under normal physiological conditions (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4).

Annotation Risk - Mitochondrial Localization:
A recent study proposes lactate-induced translocation of MGAT1 to mitochondria in activated human Tregs (zhou2024lactatesupportstreg pages 1-2). This claim, if validated, would represent a novel and context-specific localization. However, it contrasts with decades of established Golgi-resident literature and requires independent confirmation before being incorporated into core cellular component annotations. Current GO annotation should prioritize the canonical Golgi membrane localization.

4.2 Protein Complexes and Interactions

MGAT1 participates in several functionally relevant protein complexes within the Golgi membrane:

Multi-Enzyme Assemblies:
High-throughput FRET and BiFC interaction screens demonstrate that MGAT1 forms homomeric and heteromeric assemblies with other N-glycan processing enzymes, including MGAT2, MGAT3, MGAT4B, and the mannosidase MAN2A2 (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2). MAN2A2 acts as a central hub in these complexes, consistent with its sequential action immediately downstream of MGAT1 (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2). These multi-enzyme complexes likely facilitate efficient substrate channeling and coordinated N-glycan maturation.

Nucleotide Sugar Transporter Interactions:
MGAT1 associates with nucleotide sugar transporters, particularly SLC35A3 (the UDP-GlcNAc transporter), forming multi-enzyme/multi-transporter assemblies in Golgi membranes (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2). These interactions ensure efficient delivery of UDP-GlcNAc to the catalytic site and may contribute to Golgi retention (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2).

Inhibitory Interaction with MGAT4D (GnT1IP-L):
MGAT1 interacts specifically with MGAT4D/GnT1IP-L in the Golgi, where GnT1IP-L inhibits MGAT1 activity via its luminal domain (huang2015gnt1iplspecificallyinhibits pages 1-2). This regulatory interaction is predominantly observed in spermatogenic cells and provides a physiological mechanism for modulating MGAT1 activity in specific developmental contexts (huang2015gnt1iplspecificallyinhibits pages 1-2). Importantly, GnT1IP-L does not interact with other medial-Golgi GlcNAc transferases (MGAT2, MGAT3, MGAT4B, MGAT5), demonstrating specificity for MGAT1 (huang2015gnt1iplspecificallyinhibits pages 1-2).

Interaction with BRI3:
UniProt metadata indicates MGAT1 interacts with BRI3 isoforms, with stronger interaction with isoform 1 than isoform 2 (UniProt entry). This interaction may contribute to Golgi organization or enzyme regulation, though detailed functional studies are not present in the retrieved literature set.

5. ANNOTATION-RISK ASSESSMENT

5.1 Core Function vs. Pleiotropic Effects

The central annotation risk for MGAT1 is the conflation of direct enzymatic function with indirect, substrate-mediated phenotypes. MGAT1 is fundamentally a glycosyltransferase that modifies N-glycans on hundreds of glycoproteins. The biological consequences of MGAT1 activity are thus highly pleiotropic, reflecting the diverse functions of its glycoprotein substrates rather than intrinsic properties of MGAT1 itself.

High-Confidence Core Annotations:
- Molecular Function: N-acetylglucosaminyltransferase activity (EC 2.4.1.101)
- Biological Process: Protein N-linked glycosylation; complex N-glycan biosynthetic process
- Cellular Component: Golgi apparatus membrane; medial-Golgi

Well-Supported Physiological Process Annotations:
- Embryonic development (essential for viability and neural tube formation)
- T-cell development and differentiation
- Immune system development

Context-Specific Annotations Requiring Caution:
- Cancer progression, metastasis, immune evasion: These are substrate-specific effects mediated by MGAT1 modification of particular glycoproteins (e.g., CD73, integrins) in specific cellular contexts (chi2025mgat1guidedcomplexnglycans pages 1-2). Direct annotation of MGAT1 to "negative regulation of immune response" or "positive regulation of cell migration" would be misleading.
- Inflammatory response: Observed phenotypes in Mgat1-deficient models reflect altered immune cell development and receptor glycosylation, not direct MGAT1 participation in inflammatory signaling (vicente2023mannosylatedglycansimpair pages 1-2).
- Apoptosis and neuronal cell death: Associations with neurological phenotypes and cell death are secondary to failed glycoprotein maturation, not evidence of direct apoptotic functions (tang2023transcriptomicandglycomic pages 1-2).
- Mitochondrial localization and metabolic regulation: Emerging data from specialized Treg contexts (zhou2024lactatesupportstreg pages 1-2) require validation and should not replace canonical Golgi annotations without strong confirmatory evidence.

5.2 Distinguishing Direct vs. Indirect Roles

A useful principle for MGAT1 annotation is to ask: Does this process or localization reflect the direct biochemical activity of MGAT1 as a Golgi-resident glycosyltransferase, or does it reflect consequences of altered glycosylation on specific substrate proteins?

For example:
- "Protein N-glycosylation" ✓ Direct
- "Complex N-glycan biosynthetic process" ✓ Direct
- "Embryonic neural tube formation" ✓ Well-supported (essential gene)
- "T-cell receptor signaling pathway" ✗ Indirect (MGAT1 modifies TCR glycans; it does not transduce TCR signals)
- "Negative regulation of T-cell activation" ✗ Indirect (context-dependent effect via substrate glycoproteins)
- "Immune evasion" ✗ Highly context-specific (substrate-mediated in cancer)
- "Apoptosis" ✗ Indirect (consequence of failed glycoprotein function, not direct apoptotic activity)

5.3 Over-Extension Risks

Several specific annotation risks merit attention:

Avoid cytoplasmic/cytosolic/nuclear localization annotations unless strong direct evidence emerges. Current data overwhelmingly support Golgi membrane residence (kizuka2024regulationofintracellular pages 1-2, liu2026iterativebumpandholeengineering pages 1-4, huang2015gnt1iplspecificallyinhibits pages 1-2).
Mitochondrial annotations require caution. The 2024 lactate/Treg study (zhou2024lactatesupportstreg pages 1-2) is provocative but represents a single, context-specific report. Until independently validated, mitochondrial localization should be noted as emerging/provisional rather than replacing core Golgi annotations.
Signaling complex annotations are generally inappropriate. MGAT1 does not participate in canonical signal transduction complexes. It forms functional complexes with other Golgi glycosylation enzymes and transporters (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2), which is appropriate for cellular component annotation, but these should not be conflated with signaling scaffolds.
Disease-association does not equal direct function. Altered MGAT1 expression correlates with cancer, neurodegeneration, and immune disorders (chi2025mgat1guidedcomplexnglycans pages 1-2, tang2023transcriptomicandglycomic pages 1-2), but these are phenotypic associations rather than evidence for direct MGAT1 roles in oncogenesis or neurodegeneration.

6. KEY LITERATURE

Category	Reference	Journal	DOI / URL	Contribution to MGAT1 GO annotation review
Recent high-quality study	Zhou et al., 2024	Journal of Clinical Investigation	https://doi.org/10.1172/JCI175897	Reports a novel, context-specific claim that lactate increases MGAT1 expression and promotes apparent mitochondrial localization/translocation in human Tregs, linking MGAT1 to Treg OXPHOS. Useful mainly as an annotation-risk paper because it challenges the canonical Golgi-only view and likely requires independent validation before broad GO transfer (zhou2024lactatesupportstreg pages 1-2).
Recent high-quality study	Kizuka, 2024	Journal of Biological Chemistry	https://doi.org/10.1016/j.jbc.2024.107471	Authoritative recent review of mammalian N-glycan branching enzymes. Clearly places MGAT1 as the enzyme that transfers GlcNAc to Man5 structures to initiate complex-type N-glycan biosynthesis, and summarizes Golgi-resident type II membrane protein architecture and regulatory principles relevant to GO MF/BP/CC terms (kizuka2024regulationofintracellular pages 1-2).
Recent high-quality study	Hall et al., 2023	Current Issues in Molecular Biology	https://doi.org/10.3390/cimb45110575	Zebrafish study showing reduced Mgat1 activity increases oligomannose glycans, decreases complex glycans, and impairs survival, brain anlagen formation, muscle development, sensory responses, and cardiac onset. Useful for conserved developmental-process support, but should be interpreted as downstream consequences of defective N-glycan maturation (hall2023reductioninnacetylglucosaminyltransferasei pages 1-2).
Recent high-quality study	Vicente et al., 2023	Cellular & Molecular Immunology	https://doi.org/10.1038/s41423-023-01052-7	Conditional mouse thymocyte study showing Mgat1-dependent restriction of high-mannose glycans is required for normal β-selection, γδ T-cell development, and Treg generation. Strong evidence for immune-development phenotypes mediated by MGAT1-dependent N-glycan maturation (vicente2023mannosylatedglycansimpair pages 1-2).
Recent high-quality study	Tang et al., 2023	Scientific Reports	https://doi.org/10.1038/s41598-023-34787-4	Human AD transcriptomic/glycomic study showing MGAT1 upregulation correlates with increased complex N-glycan features in brain. Useful as disease-context evidence of expression change, but not strong support for direct GO process annotation beyond N-glycosylation pathway involvement (tang2023transcriptomicandglycomic pages 1-2).
Foundational biochemical / pathway paper	Huang et al., 2015	eLife	https://doi.org/10.7554/eLife.08916	Defines MGAT1 as the GlcNAc-transferase that transfers GlcNAc from UDP-GlcNAc to Man5GlcNAc2Asn in the medial Golgi to initiate hybrid/complex N-glycan synthesis. Also provides evidence for specific Golgi inhibition by GnT1IP-L/MGAT4D, relevant to regulation and interaction annotations (huang2015gnt1iplspecificallyinhibits pages 1-2).
Foundational biochemical / pathway paper	Khoder-Agha et al., 2019	Cellular and Molecular Life Sciences	https://doi.org/10.1007/s00018-019-03032-5	Demonstrates that MGAT1 forms Golgi membrane assemblies with MGAT2, MGAT3, MGAT4B, MAN2A2, and nucleotide sugar transporters including SLC35A3. Important for refined cellular-component and complex-context review, while still supporting canonical Golgi localization (khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2).
Foundational biochemical / pathway paper	Thoma et al., 2024	Glycoconjugate Journal	https://doi.org/10.1007/s10719-024-10148-9	Biochemical characterization of GnT-I ortholog showing the canonical reaction: transfer of GlcNAc from UDP-GlcNAc to the α1,3-Man arm of Man5GlcNAc2; also shows Mn2+ dependence and EDTA sensitivity. Valuable for catalytic specificity and cofactor expectations when direct human enzymology is sparse in the retrieved set (thoma2024determinationexpressionand pages 1-2).
Foundational structural / mechanistic review	Nagae et al., 2020	International Journal of Molecular Sciences	https://doi.org/10.3390/ijms21020437	Review summarizing structural and mechanistic knowledge of N-glycan maturation enzymes, including rabbit GnT-I crystal structure and exosite concepts. Useful for framing MGAT1 substrate recognition and catalytic architecture in GO molecular-function review (kizuka2024regulationofintracellular pages 1-2).
Foundational conceptual review	Abdelbary & Nolz, 2023	Immunometabolism	http://dx.doi.org/10.1097/IN9.0000000000000035	Immune-focused review that clearly explains MGAT1 as the critical step after mannose trimming that enables hybrid and then complex N-glycan formation. Useful for concise pathway description and for linking MGAT1 to T-cell developmental biology without overstating direct signaling roles (abdelbary2023nlinkedglycansan pages 1-2).
Key developmental / physiological study	Hall et al., 2023	Current Issues in Molecular Biology	https://doi.org/10.3390/cimb45110575	Supports developmental and organismal viability roles of MGAT1 through glycan maturation defects, especially in nervous-system and muscle-related phenotypes in zebrafish (hall2023reductioninnacetylglucosaminyltransferasei pages 1-2).
Key developmental / physiological study	Vicente et al., 2023	Cellular & Molecular Immunology	https://doi.org/10.1038/s41423-023-01052-7	Supports a physiological requirement for MGAT1 in thymocyte maturation and immune homeostasis, with inflammation susceptibility arising secondarily from altered thymocyte glycosylation (vicente2023mannosylatedglycansimpair pages 1-2).
Annotation-risk assessment	Chi et al., 2025	Nature Communications	https://doi.org/10.1038/s41467-025-58524-9	Shows MGAT1-dependent glycosylation of CD73 in triple-negative breast cancer can drive membrane trafficking and immune evasion. Important as a cautionary example: such cancer-specific substrate effects should not be generalized into core MGAT1 GO annotations like 'immune evasion' or broad signaling-complex localization (chi2025mgat1guidedcomplexnglycans pages 1-2).
Annotation-risk assessment	Blomberg et al., 2025	Frontiers in Immunology	https://doi.org/10.3389/fimmu.2025.1588795	MGAT1 KO in human dendritic cells abolishes hybrid/complex N-glycans and enhances CD8 T-cell activation. Useful to show that immune phenotypes can be robust yet indirect consequences of global N-glycan remodeling, arguing for caution in assigning direct inflammatory or activation-process terms to MGAT1 (blomberg2025mgat1knockoutin pages 1-2).
Annotation-risk assessment	Zhou et al., 2024	Journal of Clinical Investigation	https://doi.org/10.1172/JCI175897	Especially relevant for reviewing proposed noncanonical mitochondrial localization and metabolic roles. Strong direct experimental claim in a specialized cell context, but because it diverges from longstanding Golgi-resident consensus, it should be treated as emerging rather than replacing core MGAT1 CC annotations (zhou2024lactatesupportstreg pages 1-2, kizuka2024regulationofintracellular pages 1-2).
Annotation-risk assessment	Tang et al., 2023	Scientific Reports	https://doi.org/10.1038/s41598-023-34787-4	Disease-association paper that links altered MGAT1 expression with AD-related glycomic changes; useful to distinguish expression correlation and pathology context from direct causal GO process annotation such as apoptosis or neurodegeneration (tang2023transcriptomicandglycomic pages 1-2).

Table: This table compiles the most relevant literature for MGAT1 GO annotation review, separating core biochemical and developmental evidence from context-specific studies that pose annotation-risk. It is designed to help distinguish canonical MGAT1 function and localization from indirect disease- or cell-type-specific effects.

SUMMARY RECOMMENDATIONS FOR GO ANNOTATION

Based on comprehensive literature review, the following annotation framework is recommended:

Molecular Function (High Confidence):
- N-acetylglucosaminyltransferase activity (EC 2.4.1.101)
- UDP-N-acetylglucosamine:α-1,3-D-mannoside β-1,2-N-acetylglucosaminyltransferase activity
- Metal ion binding (Mn²⁺)

Biological Process (High Confidence):
- Protein N-linked glycosylation
- Complex N-glycan biosynthetic process
- Asparagine-linked glycosylation

Biological Process (Well-Supported, Organism-Level):
- Embryonic development
- Neural tube formation
- T-cell differentiation
- Immune system development

Cellular Component (High Confidence):
- Golgi apparatus membrane
- Medial-Golgi
- Integral component of membrane

Avoid or Use with Extreme Caution:
- Direct annotation to apoptosis, immune evasion, inflammatory response, cancer progression (these are indirect, substrate-mediated)
- Cytoplasm, cytosol, nucleus (not supported by current evidence)
- Mitochondrion (emerging claim requiring validation)
- Generic "signaling complex" terms (not applicable to glycosyltransferase complexes)

Interaction Annotations (Moderate Confidence):
- Physical interaction with MGAT2, MGAT3, MGAT4B, MAN2A2, SLC35A3, MGAT4D, BRI3
- Participation in Golgi multi-enzyme assemblies

This framework distinguishes the well-established core function of MGAT1 as a Golgi-resident glycosyltransferase from context-specific, substrate-mediated phenotypes that arise from altered N-glycan structures on diverse glycoprotein substrates. Proper annotation should reflect this distinction to avoid over-extending MGAT1's functional repertoire beyond its direct biochemical role.

References: Citations are embedded throughout the report using context IDs () corresponding to specific literature sources detailed in the Key Literature table (artifact-02).

References

(kizuka2024regulationofintracellular pages 1-2): Yasuhiko Kizuka. Regulation of intracellular activity of n-glycan branching enzymes in mammals. Jul 2024. URL: https://doi.org/10.1016/j.jbc.2024.107471, doi:10.1016/j.jbc.2024.107471. This article has 28 citations and is from a domain leading peer-reviewed journal.
(abdelbary2023nlinkedglycansan pages 1-2): Mahmoud Abdelbary and Jeffrey C. Nolz. N-linked glycans: an underappreciated key determinant of t cell development, activation, and function. Immunometabolism (Cobham, Surrey), 5:e00035-e00035, Oct 2023. URL: https://doi.org/10.1097/in9.0000000000000035, doi:10.1097/in9.0000000000000035. This article has 9 citations.
(liu2026iterativebumpandholeengineering pages 1-4): Yu Liu, Saskia Pieters, Ganka Bineva-Todd, Mert Sagiroglugil, Sean A. Burnap, Freya Hoddle, Anna Cioce, Andre Ohara, Kevin Bruemmer, Carolyn R. Bertozzi, Karen Polizzi, Weston B. Struwe, Carme Rovira, and Benjamin Schumann. Iterative bump-and-hole engineering creates a bioorthogonal reporter for n -acetylglucosaminyltransferase i. bioRxiv, Jan 2026. URL: https://doi.org/10.64898/2026.01.16.699845, doi:10.64898/2026.01.16.699845. This article has 0 citations.
(thoma2024determinationexpressionand pages 1-2): Julia Thoma, Reingard Grabherr, and Erika Staudacher. Determination, expression and characterization of an udp-n-acetylglucosamine:α-1,3-d-mannoside β-1,2-n-acetylglucosaminyltransferase i (gnt-i) from the pacific oyster, crassostrea gigas. Glycoconjugate Journal, 41:151-162, Apr 2024. URL: https://doi.org/10.1007/s10719-024-10148-9, doi:10.1007/s10719-024-10148-9. This article has 3 citations and is from a peer-reviewed journal.
(huang2015gnt1iplspecificallyinhibits pages 1-2): Hung-Hsiang Huang, Antti Hassinen, Subha Sundaram, Andrej-Nikolai Spiess, Sakari Kellokumpu, and Pamela Stanley. Gnt1ip-l specifically inhibits mgat1 in the golgi via its luminal domain. eLife, Sep 2015. URL: https://doi.org/10.7554/elife.08916, doi:10.7554/elife.08916. This article has 30 citations and is from a domain leading peer-reviewed journal.
(khoderagha2019nacetylglucosaminyltransferasesandnucleotide pages 1-2): Fawzi Khoder-Agha, Paulina Sosicka, Maria Escriva Conde, Antti Hassinen, Tuomo Glumoff, Mariusz Olczak, and Sakari Kellokumpu. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme–multi-transporter assemblies in golgi membranes in vivo. Cellular and Molecular Life Sciences: CMLS, 76:1821-1832, Feb 2019. URL: https://doi.org/10.1007/s00018-019-03032-5, doi:10.1007/s00018-019-03032-5. This article has 57 citations.
(hall2023reductioninnacetylglucosaminyltransferasei pages 1-2): M. Kristen Hall, Cody J. Hatchett, Sergei Shalygin, Parastoo Azadi, and Ruth A. Schwalbe. Reduction in n-acetylglucosaminyltransferase-i activity decreases survivability and delays development of zebrafish. Current Issues in Molecular Biology, 45:9165-9180, Nov 2023. URL: https://doi.org/10.3390/cimb45110575, doi:10.3390/cimb45110575. This article has 7 citations.
(vicente2023mannosylatedglycansimpair pages 1-2): Manuel M. Vicente, Inês Alves, Ângela Fernandes, Ana M. Dias, Beatriz Santos-Pereira, Elena Pérez-Anton, Sofia Santos, Tao Yang, Alexandra Correia, Anja Münster-Kühnel, Afonso R. M. Almeida, Sarina Ravens, Gabriel A. Rabinovich, Manuel Vilanova, Ana E. Sousa, and Salomé S. Pinho. Mannosylated glycans impair normal t-cell development by reprogramming commitment and repertoire diversity. Cellular and Molecular Immunology, 20:955-968, Jun 2023. URL: https://doi.org/10.1038/s41423-023-01052-7, doi:10.1038/s41423-023-01052-7. This article has 41 citations and is from a peer-reviewed journal.
(chi2025mgat1guidedcomplexnglycans pages 1-2): Junlong Jack Chi, Ping Xie, Mary Hongying Cheng, Yueming Zhu, Xin Cui, Joshua Watson, Lidan Zeng, Amad Uddin, Hoang Nguyen, Lei Li, Kelley Moremen, April Reedy, Megan Wyatt, Adam Marcus, Mingji Dai, Chrystal M. Paulos, Massimo Cristofanilli, William J. Gradishar, Shaying Zhao, Kevin Kalinsky, Mine-Chie Hung, Ivet Bahar, Bin Zhang, and Yong Wan. Mgat1-guided complex n-glycans on cd73 regulate immune evasion in triple-negative breast cancer. Nature Communications, Apr 2025. URL: https://doi.org/10.1038/s41467-025-58524-9, doi:10.1038/s41467-025-58524-9. This article has 15 citations and is from a highest quality peer-reviewed journal.
(zhou2024lactatesupportstreg pages 1-2): Jinren Zhou, Jian Gu, Qufei Qian, Yigang Zhang, Tianning Huang, Xiangyu Li, Zhuoqun Liu, Qing Shao, Yuan Liang, Lei Qiao, Xiaozhang Xu, Qiuyang Chen, Zibo Xu, Yu Li, Ji Gao, Yufeng Pan, Yiming Wang, Roderick O’Connor, Keli L. Hippen, Ling Lu, and Bruce R. Blazar. Lactate supports treg function and immune balance via mgat1 effects on n-glycosylation in the mitochondria. Journal of Clinical Investigation, Sep 2024. URL: https://doi.org/10.1172/jci175897, doi:10.1172/jci175897. This article has 55 citations and is from a highest quality peer-reviewed journal.
(blomberg2025mgat1knockoutin pages 1-2): Anne Louise Blomberg, Betina Lyngfeldt Henriksen, Weihua Tian, Kerstin Skovgaard, Sarah Line Skovbakke, and Steffen Goletz. Mgat1 knockout in human dendritic cells enhance cd8+ t cell activation. Frontiers in Immunology, Dec 2025. URL: https://doi.org/10.3389/fimmu.2025.1588795, doi:10.3389/fimmu.2025.1588795. This article has 0 citations and is from a peer-reviewed journal.
(liu2024abioorthogonalprecision pages 1-2): Yu Liu, Ganka Bineva-Todd, Richard W. Meek, Laura Mazo, Beatriz Piniello, Olga Moroz, Sean A. Burnap, Nadima Begum, André Ohara, Chloe Roustan, Sara Tomita, Svend Kjaer, Karen Polizzi, Weston B. Struwe, Carme Rovira, Gideon J. Davies, and Benjamin Schumann. A bioorthogonal precision tool for human n-acetylglucosaminyltransferase v. Journal of the American Chemical Society, 146:26707-26718, Sep 2024. URL: https://doi.org/10.1021/jacs.4c05955, doi:10.1021/jacs.4c05955. This article has 10 citations and is from a highest quality peer-reviewed journal.
(biswas2020promiscuityandspecificity pages 1-2): Ansuman Biswas and Mukund Thattai. Promiscuity and specificity of eukaryotic glycosyltransferases. Biochemical Society Transactions, 48:891-900, Jun 2020. URL: https://doi.org/10.1042/bst20190651, doi:10.1042/bst20190651. This article has 62 citations and is from a peer-reviewed journal.
(tang2023transcriptomicandglycomic pages 1-2): Xinyu Tang, Jennyfer Tena, Jacopo Di Lucente, Izumi Maezawa, Danielle J. Harvey, Lee-Way Jin, Carlito B. Lebrilla, and Angela M. Zivkovic. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to alzheimer’s disease. Scientific Reports, May 2023. URL: https://doi.org/10.1038/s41598-023-34787-4, doi:10.1038/s41598-023-34787-4. This article has 45 citations and is from a peer-reviewed journal.

📚 Additional Documentation

Notes

(MGAT1-notes.md)

MGAT1 (human, P26572) — gene review notes

Identity and core enzymology

HGNC:7044, MGAT1, chromosome 5. Synonyms GGNT1, GLCT1, GLYT1, MGAT; protein name
"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"; common
enzyme names GnT-I / GlcNAc-TI. EC 2.4.1.101. CAZy family GT13. 445 aa.
Type II single-pass membrane protein (UniProt P26572): cytoplasmic tail 1-6,
TM 7-29, lumenal 30-445; active site His289 (proton acceptor); Mn2+-binding
residue 211; substrate-binding residues 115/142/188/210/320; disulfides 113-143,
237-303 (by similarity to rabbit P27115).
Core reaction (UniProt CATALYTIC ACTIVITY, RHEA:11456): transfers GlcNAc from
UDP-GlcNAc to the alpha-1,3-Man arm of Man5GlcNAc2-Asn-[protein], forming
beta-1,2-GlcNAc. This is the first committed/gatekeeper step converting
high-mannose (oligomannose) N-glycans into hybrid and complex N-glycans, creating
the obligate substrate for downstream MAN2A1/MAN2A2 (alpha-mannosidase II) and
MGAT2/MGAT4/MGAT5 branching. Cofactor Mn2+ (UniProt COFACTOR).
Originally cloned by complementation of the N-glycosylation defect of the Lec1 CHO
mutant; the protein is "the medial Golgi transferase that initiates complex
N-linked carbohydrate formation" [PMID:1702225 title; abstract: "a human gene
encoding N-acetylglucosaminyltransferase I (GlcNAc-TI; EC 2.4.1.101) by
complementation of the glycosylation defect in the Lec1 Chinese hamster ovary (CHO)
cell mutant ... full-length cDNA encoding human GlcNAc-TI activity. The overall
features of the cDNA and deduced protein sequence (445 amino acids) are typical of
other Golgi transferases that are type II transmembrane proteins."].
Catalytic activity / function re-confirmed in a cell-free glycoenzyme pipeline
(water-soluble SIMPLEx GTs remodel glycans) PMID:36280670; UniProt cites this as
ECO:0000269 evidence for FUNCTION + CATALYTIC ACTIVITY. The paper's abstract is
about a general 98-GT pipeline (human-origin GTs, complex-type N-glycan remodeling
on trastuzumab); MGAT1/GnT-I is one of the enzymes used. Treat the EXP MF
annotation as curator-verified (full text available in cache) — do NOT REMOVE
because the abstract is generic.

Subcellular localization (experimental)

Golgi apparatus membrane; medial Golgi. BiFC in live cells shows GnTI (MGAT1) forms
Golgi-localized homodimers and a functionally relevant medial-Golgi heterodimer
with GnTII (MGAT2); signal "detected only in the Golgi membranes of live cells"
[PMID:20378551 "the BiFC signal with GnTI was detected only in the Golgi membranes
of live cells"; "the medial Golgi enzymes GnTI and GnTII also assemble into
Golgi-localized homodimers in live cells"]. UniProt SUBCELLULAR LOCATION cites
PMID:20378551 for Golgi apparatus membrane.
UniProt also lists "Cytoplasm, perinuclear region" from PMID:30983867, where
MGAT1 co-localizes with BRI3 isoform 1 at the perinuclear region. The perinuclear
signal is consistent with the (peri-Golgi) location of a Golgi enzyme; the
IEA "perinuclear region of cytoplasm" (GO:0048471) annotation derives from this.

Protein interactions

Interacts with MGAT4D (GnT1IP) — UniProt SUBUNIT (by similarity to P27808); GnT1IP-L
inhibits MGAT1 in the Golgi via its lumenal domain (regulatory; spermatogenic
context) [Falcon: huang2015 = PMID:26371591 eLife, NOT in cache → notes only].
Interacts with BRI3 (ITM2C/BRI3 isoforms 1>2) by Y2H + co-IP + colocalization
[PMID:30983867 "MGAT1 ... were confirmed as interaction partners by using
cotransformation in yeast cells and coimmunoprecipitation from mammalian cell
lines"; "intense colocalization of BRI3 with MGAT1, especially in the perinuclear
area"]. This is the basis of the IPI GO:0005515 "protein binding". BRI3 is a poorly
characterized lysosomal/TNF-pathway protein; the interaction has no established
link to MGAT1 catalytic function → generic protein binding, over-annotation.
Forms homo- and hetero-dimers/multi-enzyme assemblies with other Golgi
N-glycosyltransferases (MGAT2, GalT, SiaT) and, per Falcon, with MAN2A2 and
SLC35A3 (UDP-GlcNAc transporter) [PMID:20378551 for GnTI-GnTII; Falcon:
khoderagha2019 = PMID:30659329 CMLS, NOT in cache → notes only].

Physiology / biological process (mostly via substrate glycans — non-core)

Mgat1-null mouse is embryonic lethal (~E9.5-10.5) with neural-tube defects; Lec1
CHO mutant lacks GnT-I activity (gatekeeper of complex N-glycans). Indispensable
for complex N-glycan synthesis. [Falcon synthesis; classic Stanley/Ioffe-Stanley
and Metzler results — not in our cache, recorded here as background.]
Falcon-cited downstream/pleiotropic roles (T-cell development/beta-selection/Treg,
dendritic-cell CD8 activation, zebrafish development, TNBC CD73 immune evasion,
AD glycomics, lactate/Treg "mitochondrial MGAT1"): these are consequences of
altered N-glycan structures on substrate glycoproteins, not direct MGAT1 molecular
functions. None are in our publications cache (no fetchable cached PMID), so they
are recorded as notes/background only and not used as supporting_text. They do not
warrant direct GO process annotations for MGAT1.

Reactome

R-HSA-964768 "Addition of GlcNAc to the glycan on the A arm": "This is the first
committed step in the synthesis of complex and hybrid N-glycans" — TAS basis for
the MGAT1 MF and the ERGIC membrane location.
R-HSA-9683648/9694656 "Spike trimer glycoside chains are extended": "The
N-acetylglucosaminyltransferase called GlcNAc-TI (MGAT1) adds a GlcNAc residue in
the core of some high-mannose chains" — viral (SARS-CoV) spike N-glycan maturation;
basis of TAS acetylglucosaminyltransferase activity and "viral protein processing".
R-HSA-9683686/9694548 "Maturation of spike protein": viral spike N-glycosylation
pathway; basis of TAS GO:0019082 "viral protein processing". This is the same
housekeeping N-glycan-maturation activity applied to a viral glycoprotein substrate
— keep as non-core (it is not a dedicated antiviral/viral function of MGAT1).

Annotation strategy summary

Core MF: GO:0003827 (specific GlcNAc-TI activity) — collapse the generic
GO:0008375 "acetylglucosaminyltransferase activity" onto this. Mn2+ binding
(GO:0030145) is a genuine experimentally supported cofactor MF.
Core BP: GO:0006487 protein N-linked glycosylation (specifically the
oligomannose->hybrid/complex committed step). GO:0009101 glycoprotein biosynthetic
process is an over-general InterPro parent.
Core CC: GO:0000139 Golgi membrane (IDA). GO:0005794 Golgi apparatus (IBA) accept.
GO:0033116 ERGIC membrane (Reactome TAS) keep-as-non-core. GO:0048471 perinuclear
region keep-as-non-core (peri-Golgi). Exosome/extracellular vesicle/membrane HDA
proteomics hits = over-annotation (secretory-pathway carryover, not function).
Generic GO:0005515 protein binding (BRI3 Y2H) → over-annotated per guidelines.
viral protein processing (GO:0019082) Reactome TAS → keep-as-non-core (substrate
application of the housekeeping activity).

Falcon integration (2026-06-21)

Falcon report read in full; it is well-organized and its core-vs-pleiotropic framing
matches GO best practice. Used / rejected:

USED (concordant, anchored to verifiable sources): GT13 / type II Golgi membrane
enzyme; UDP-GlcNAc donor + Mn2+ cofactor; gatekeeper first committed step
(Man5GlcNAc2 alpha-1,3 arm); medial-Golgi multi-enzyme assemblies; explicit
"core enzymatic function vs indirect substrate-mediated phenotype" annotation
principle; caution against cytosol/nucleus/mitochondrion CC and against
immune-evasion/apoptosis/inflammation BP. These are independently supported by
UniProt P26572, PMID:1702225, PMID:20378551, and Reactome R-HSA-964768.
REJECTED / DOWNGRADED TO NOTES (no fetchable cached PMID; could not verify
verbatim, and CLAUDE.md forbids citing them as supporting_text):
huang2015 GnT1IP-L inhibition (cited as eLife 2015; resolves to PMID:26371591,
not in cache) — recorded as background for the MGAT4D interaction only.
khoderagha2019 multi-enzyme/SLC35A3 assemblies (CMLS; PMID:30659329, not in
cache) — background only.
vicente2023 / blomberg2025 / chi2025 / zhou2024 / tang2023 / hall2023 immune,
cancer, AD, "mitochondrial MGAT1" claims — all downstream/substrate-mediated or
single-context emerging claims, none in cache; not used for annotation. The
Falcon report itself flags these as annotation-risk, which I agree with.
Several Falcon "page" citation tokens (e.g. liu2026 bioRxiv preprint) are
preprints/low-citation and not load-bearing here.
DATING NOTE: Falcon assigns PMID:1702225 to 1990 (correct PNAS year); the cached
record header says 1990. UniProt RN[1] lists the PNAS 87:9948-9952(1990). Fine.
The Falcon report is added to references as a file: reference with relevance MEDIUM,
used only to anchor the core-vs-pleiotropic synthesis; all substantive claims are
cited to primary papers / UniProt / Reactome.

📄 View Raw YAML

id: P26572
gene_symbol: MGAT1
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  MGAT1 is alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
  (GlcNAc-transferase I, GnT-I; EC 2.4.1.101), a Mn2+-dependent, UDP-GlcNAc-using
  glycosyltransferase of CAZy family GT13. It is a type II single-pass membrane
  protein of the medial Golgi apparatus, with a short N-terminal cytoplasmic tail,
  a single transmembrane signal-anchor, and a large lumenal catalytic domain. MGAT1
  catalyzes the first committed (gatekeeper) step of complex and hybrid N-glycan
  biosynthesis: it transfers a single N-acetylglucosamine in beta-1,2 linkage onto
  the alpha-1,3-linked mannose arm of the Man5GlcNAc2 N-glycan that is attached to
  asparagine residues of glycoproteins traversing the secretory pathway. The product
  (GlcNAc-beta1,2-Man-alpha1,3-arm) is the obligate substrate for subsequent trimming
  by Golgi alpha-mannosidase II (MAN2A1/MAN2A2) and for further branching by MGAT2,
  MGAT4 and MGAT5, so loss of MGAT1 activity blocks all hybrid and complex N-glycan
  synthesis and leaves only oligomannose structures (as in the Chinese hamster ovary
  Lec1 mutant from which the gene was cloned by complementation). Because complex
  N-glycans decorate hundreds of secreted and cell-surface glycoproteins, MGAT1 is
  essential for normal mammalian development and broadly influences cell-surface
  receptor biology, but its own molecular activity is a single, highly conserved
  glycosyltransfer reaction carried out in the Golgi.
existing_annotations:
- term:
    id: GO:0003827
    label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetically inferred core molecular function and exactly the
      experimentally established activity of MGAT1/GnT-I (EC 2.4.1.101). This is
      the specific, informative GlcNAc-TI term and is the core function of the gene.
    action: ACCEPT
- term:
    id: GO:0006487
    label: protein N-linked glycosylation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Correct core biological process. MGAT1 performs the committed step that
      converts oligomannose to hybrid/complex N-glycans during protein N-linked
      glycosylation. Concordant with the IDA annotation to the same term. Accept.
    action: ACCEPT
- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic inference of Golgi localization, consistent with the
      experimental IDA Golgi membrane annotation and with MGAT1 being a medial-Golgi
      glycosyltransferase. The more specific Golgi membrane term is preferable, but
      this organelle-level call is correct. Accept.
    action: ACCEPT
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic mapping from the UniProt subcellular-location keyword (Golgi
      apparatus membrane). Same content as the experimental IDA Golgi membrane
      annotation; this is the core, correct subcellular location. Accept.
    action: ACCEPT
- term:
    id: GO:0003827
    label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic prediction of the specific GlcNAc-TI activity. Identical in content
      to the IBA/IDA/EXP/TAS annotations to the same term and is the core function.
      Accept.
    action: ACCEPT
- term:
    id: GO:0008375
    label: acetylglucosaminyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Correct but over-general parent of the specific GlcNAc-TI activity. The
      precise child term GO:0003827 (alpha-1,3-mannosylglycoprotein
      2-beta-N-acetylglucosaminyltransferase activity) is experimentally supported
      and should be used instead.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003827
      label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
- term:
    id: GO:0009101
    label: glycoprotein biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Over-general InterPro-derived process term. MGAT1 acts specifically in protein
      N-linked glycosylation (the oligomannose-to-complex committed step); the
      specific N-linked glycosylation term is more informative.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0006487
      label: protein N-linked glycosylation
- term:
    id: GO:0048471
    label: perinuclear region of cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic mapping from the UniProt "Cytoplasm, perinuclear region" location,
      which derives from PMID:30983867 where MGAT1 co-localizes with BRI3 isoform 1
      in the perinuclear area (consistent with the peri-Golgi position of a Golgi
      enzyme). This is a juxta-Golgi appearance rather than a distinct cytoplasmic
      compartment of MGAT1 function; keep as a plausible secondary location but not
      core.
    action: KEEP_AS_NON_CORE
    supported_by:
    - reference_id: PMID:30983867
      supporting_text: >-
        intense colocalization of BRI3 with MGAT1, especially in the
        perinuclear area of Huh7 cells
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:30983867
  qualifier: enables
  review:
    summary: >-
      Generic "protein binding" from a yeast two-hybrid plus co-IP/colocalization
      interaction with BRI3 (ITM2C). Per curation guidelines this term is
      uninformative about molecular function, and the BRI3 interaction has no
      established link to MGAT1 catalytic activity or the N-glycosylation pathway
      (BRI3 is a poorly characterized lysosomal/TNF-pathway protein). Over-annotation;
      not a core function.
    action: MARK_AS_OVER_ANNOTATED
    supported_by:
    - reference_id: PMID:30983867
      supporting_text: >-
        IFITM3 and MGAT1 proteins were confirmed as interaction partners by using
        cotransformation in yeast cells and coimmunoprecipitation from mammalian
        cell lines
- term:
    id: GO:0003827
    label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-964768
  qualifier: enables
  review:
    summary: >-
      Reactome traceable annotation for the reaction "Addition of GlcNAc to the
      glycan on the A arm", described as the first committed step in complex/hybrid
      N-glycan synthesis. Exactly the core GlcNAc-TI activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: Reactome:R-HSA-964768
      supporting_text: >-
        This is the first committed step in the synthesis of complex and hybrid
        N-glycans
- term:
    id: GO:0003827
    label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
  evidence_type: EXP
  original_reference_id: PMID:36280670
  qualifier: enables
  review:
    summary: >-
      Experimental support for the GlcNAc-TI activity. PMID:36280670 (Jaroentomeechai
      et al.) is a cell-free glycoenzyme pipeline in which MGAT1/GnT-I was produced as
      a water-soluble enzyme and used in N-glycan remodeling; UniProt cites it as
      ECO:0000269 evidence for MGAT1 catalytic activity. The abstract describes the
      general 98-glycosyltransferase platform rather than MGAT1 by name, but the
      curated experimental evidence supports the specific activity, which is in any
      case the well-established core function. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:36280670
      supporting_text: >-
        facile production of 98 difficult-to-express GTs, predominantly of human
        origin
- term:
    id: GO:0019082
    label: viral protein processing
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9683686
  qualifier: involved_in
  review:
    summary: >-
      Reactome annotation placing MGAT1 in SARS-CoV spike-protein maturation, where
      it performs its normal N-glycan branching on a viral glycoprotein substrate.
      This is the housekeeping GlcNAc-TI activity applied to a viral substrate rather
      than a dedicated antiviral/viral-processing function of MGAT1; keep but not core.
    action: KEEP_AS_NON_CORE
- term:
    id: GO:0019082
    label: viral protein processing
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9694548
  qualifier: involved_in
  review:
    summary: >-
      Duplicate Reactome "Maturation of spike protein" annotation (different stable
      ID). Same interpretation as the other viral protein processing annotation:
      substrate application of the normal Golgi N-glycan branching activity, not a
      core viral function.
    action: KEEP_AS_NON_CORE
- term:
    id: GO:0008375
    label: acetylglucosaminyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9683648
  qualifier: enables
  review:
    summary: >-
      Reactome MF annotation from "Spike trimer glycoside chains are extended", which
      states GlcNAc-TI (MGAT1) adds a GlcNAc residue to high-mannose chains. Correct
      direction but over-general; the specific GlcNAc-TI term GO:0003827 captures the
      activity.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003827
      label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
    supported_by:
    - reference_id: Reactome:R-HSA-9683648
      supporting_text: >-
        The N-acetylglucosaminyltransferase called GlcNAc-TI (MGAT1) adds a GlcNAc
        residue in the core of some high-mannose chains
- term:
    id: GO:0008375
    label: acetylglucosaminyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9694656
  qualifier: enables
  review:
    summary: >-
      Duplicate Reactome "Spike trimer glycoside chains are extended" MF annotation.
      Same over-general issue; replace with the specific GlcNAc-TI activity term.
    action: MODIFY
    proposed_replacement_terms:
    - id: GO:0003827
      label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
- term:
    id: GO:0033116
    label: endoplasmic reticulum-Golgi intermediate compartment membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-964768
  qualifier: located_in
  review:
    summary: >-
      Reactome places the GlcNAc-TI reaction at the ERGIC membrane. The
      best-supported experimental location is the medial-Golgi membrane (IDA,
      PMID:20378551); an ERGIC pool is biologically plausible for an early
      secretory-pathway glycosyltransferase but is secondary to the Golgi location.
      Keep as non-core.
    action: KEEP_AS_NON_CORE
- term:
    id: GO:0033116
    label: endoplasmic reticulum-Golgi intermediate compartment membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9683648
  qualifier: located_in
  review:
    summary: >-
      Duplicate ERGIC-membrane location from the viral spike Reactome reaction. Same
      interpretation: plausible secondary secretory-pathway location, secondary to
      the experimentally supported Golgi membrane. Keep as non-core.
    action: KEEP_AS_NON_CORE
- term:
    id: GO:0033116
    label: endoplasmic reticulum-Golgi intermediate compartment membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9694656
  qualifier: located_in
  review:
    summary: >-
      Duplicate ERGIC-membrane location (third Reactome stable ID). Keep as a
      plausible secondary location; the core compartment is the Golgi membrane.
    action: KEEP_AS_NON_CORE
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: IDA
  original_reference_id: PMID:20378551
  qualifier: located_in
  review:
    summary: >-
      Direct experimental localization: live-cell bimolecular fluorescence
      complementation showed MGAT1 (GnTI) forms Golgi-localized homodimers and a
      medial-Golgi heterodimer with MGAT2 (GnTII), with signal detected only in the
      Golgi membranes. This is the core, experimentally supported subcellular
      location. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:20378551
      supporting_text: >-
        the BiFC signal with GnTI was detected only in the Golgi membranes of
        live cells
- term:
    id: GO:0003827
    label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:1702225
  qualifier: enables
  review:
    summary: >-
      Foundational direct experimental support: the human gene was identified by
      complementation of the N-glycosylation defect of the Lec1 CHO mutant, and the
      cloned cDNA confers GlcNAc-TI (EC 2.4.1.101) activity. This is the defining
      core molecular function of MGAT1. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:1702225
      supporting_text: >-
        full-length cDNA encoding human GlcNAc-TI activity
- term:
    id: GO:0006487
    label: protein N-linked glycosylation
  evidence_type: IDA
  original_reference_id: PMID:1702225
  qualifier: involved_in
  review:
    summary: >-
      Direct experimental support for involvement in protein N-linked glycosylation:
      MGAT1 is "the medial Golgi transferase that initiates complex N-linked
      carbohydrate formation". Core biological process. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:1702225
      supporting_text: >-
        the medial Golgi transferase that initiates complex N-linked carbohydrate
        formation
- term:
    id: GO:0030145
    label: manganese ion binding
  evidence_type: IDA
  original_reference_id: PMID:1702225
  qualifier: enables
  review:
    summary: >-
      MGAT1/GnT-I is a Mn2+-dependent glycosyltransferase (UniProt COFACTOR: Mn2+;
      GT-A-type metal coordination of the UDP-GlcNAc donor). Manganese ion binding is
      a genuine, experimentally supported cofactor-binding molecular function and a
      core enzymatic property. Accept.
    action: ACCEPT
- term:
    id: GO:1903561
    label: extracellular vesicle
  evidence_type: HDA
  original_reference_id: PMID:24769233
  qualifier: located_in
  review:
    summary: >-
      High-throughput proteomic detection in cerebrospinal-fluid extracellular
      vesicles. MGAT1 is a Golgi-resident type II membrane enzyme; its presence in
      a vesicle proteome reflects secretory-pathway/membrane carryover rather than a
      functional extracellular-vesicle localization. Over-annotation.
    action: MARK_AS_OVER_ANNOTATED
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  qualifier: located_in
  review:
    summary: >-
      High-throughput exosome proteomics (expressed prostatic secretions). As with
      the other vesicle proteomics hits, this is bulk-MS detection in an exosome
      preparation, not evidence that MGAT1 functions in exosomes; it contradicts the
      well-established Golgi membrane location. Over-annotation.
    action: MARK_AS_OVER_ANNOTATED
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  qualifier: located_in
  review:
    summary: >-
      Trivial location from an NK-cell membrane-proteome MS dataset. MGAT1 is a
      single-pass membrane protein, so "membrane" is correct but uninformative; the
      specific Golgi membrane term supersedes it.
    action: MARK_AS_OVER_ANNOTATED
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19199708
  qualifier: located_in
  review:
    summary: >-
      High-throughput parotid-gland exosome proteomics. Same interpretation as the
      other exosome HDA annotation: secretory-pathway carryover detected by bulk MS,
      not a functional exosomal location. Over-annotation.
    action: MARK_AS_OVER_ANNOTATED
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:1702225
  title: Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi
    transferase that initiates complex N-linked carbohydrate formation.
  findings:
  - statement: >-
      The human MGAT1 gene was identified by complementation of the N-glycosylation
      defect of the Lec1 CHO mutant, and the cloned full-length cDNA encodes an active
      GlcNAc-TI (EC 2.4.1.101); the 445-aa protein is a type II Golgi transferase.
    supporting_text: >-
      full-length cDNA encoding human GlcNAc-TI activity. The overall features of the
      cDNA and deduced protein sequence (445 amino acids) are typical of other Golgi
      transferases that are type II transmembrane proteins.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified foundational cloning/characterization (Kumar, Stanley et al.,
      PNAS 1990). Establishes the core GlcNAc-TI activity, the initiation of complex
      N-glycan formation, and the medial-Golgi type II topology. Abstract-only in
      cache; supporting_text is a verbatim quote from the abstract. Basis of the IDA
      MF and BP annotations.
- id: PMID:20378551
  title: Golgi N-glycosyltransferases form both homo- and heterodimeric enzyme complexes
    in live cells.
  findings:
  - statement: >-
      Live-cell BiFC shows MGAT1 (GnTI) forms Golgi-localized homodimers and a
      functionally relevant medial-Golgi heterodimer with MGAT2 (GnTII); BiFC signal
      was detected only in the Golgi membranes.
    supporting_text: >-
      the BiFC signal with GnTI was detected only in the Golgi membranes of live cells
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified, full text in cache. Directly supports the IDA Golgi membrane
      localization and the medial-Golgi multi-enzyme (GnTI-GnTII) assembly.
- id: PMID:36280670
  title: A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free
    remodeling of glycans.
  findings:
  - statement: >-
      A SIMPLEx-based platform produced ~98 difficult-to-express glycosyltransferases
      (predominantly human) as water-soluble, catalytically active enzymes for
      cell-free glycan remodeling, including complex-type N-glycan synthesis; UniProt
      cites this work as experimental evidence for MGAT1 catalytic activity.
    supporting_text: >-
      facile production of 98 difficult-to-express GTs, predominantly of human origin
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified, full text in cache. The abstract describes the general
      glycoenzyme platform rather than MGAT1 by name, but UniProt (P26572) cites it
      as ECO:0000269 evidence for MGAT1 FUNCTION/CATALYTIC ACTIVITY; the curators read
      the full text. Per guidelines, the EXP MF annotation is retained, not removed,
      because the abstract is generic.
- id: PMID:30983867
  title: Identification of IFITM3 and MGAT1 as novel interaction partners of BRI3
    by yeast two-hybrid screening.
  findings:
  - statement: >-
      MGAT1 was identified and confirmed (Y2H, co-IP, confocal colocalization) as an
      interaction partner of BRI3 (stronger with BRI3 isoform a/1), colocalizing in
      the perinuclear region.
    supporting_text: >-
      intense colocalization of BRI3 with MGAT1, especially in the perinuclear
      area of Huh7 cells
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified, full text in cache. Supports only a generic protein-binding
      (IPI) annotation and the perinuclear (peri-Golgi) localization; the BRI3
      interaction has no established link to MGAT1 catalytic function.
- id: PMID:24769233
  title: 'Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive
    dataset.'
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput CSF extracellular-vesicle proteomics; basis of an HDA
      "extracellular vesicle" location that reflects secretory-pathway carryover,
      not MGAT1 function.
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
    secretions in urine.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput exosome proteomics; basis of an HDA "extracellular exosome"
      location, an over-annotation for a Golgi enzyme.
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput NK-cell membrane proteome; basis of a trivial HDA "membrane"
      location.
- id: PMID:19199708
  title: Proteomic analysis of human parotid gland exosomes by multidimensional protein
    identification technology (MudPIT).
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput parotid-gland exosome proteomics; basis of an HDA
      "extracellular exosome" location, an over-annotation for a Golgi enzyme.
- id: Reactome:R-HSA-964768
  title: Addition of GlcNAc to the glycan on the A arm
  findings:
  - statement: >-
      Reactome reaction for the MGAT1-catalyzed first committed step in complex and
      hybrid N-glycan synthesis, modeled at the ER-Golgi intermediate compartment /
      Golgi membrane.
    supporting_text: >-
      This is the first committed step in the synthesis of complex and hybrid
      N-glycans
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Reactome reaction consistent with the primary literature; basis of the TAS
      GlcNAc-TI MF and an ERGIC-membrane location.
- id: Reactome:R-HSA-9683648
  title: Spike trimer glycoside chains are extended
  findings:
  - statement: >-
      Reactome reaction in which GlcNAc-TI (MGAT1) adds a GlcNAc residue to
      high-mannose chains of the SARS-CoV spike glycoprotein during its N-glycan
      maturation.
    supporting_text: >-
      The N-acetylglucosaminyltransferase called GlcNAc-TI (MGAT1) adds a GlcNAc
      residue in the core of some high-mannose chains
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Reactome viral N-glycan-maturation reaction; basis of the TAS
      acetylglucosaminyltransferase MF and ERGIC-membrane location for the spike
      pathway. Substrate application of the normal MGAT1 activity.
- id: Reactome:R-HSA-9683686
  title: Maturation of spike protein
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Reactome SARS-CoV spike maturation pathway; basis of a TAS "viral protein
      processing" process annotation reflecting MGAT1's normal N-glycan branching on
      a viral substrate.
- id: Reactome:R-HSA-9694548
  title: Maturation of spike protein
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Duplicate Reactome spike-maturation pathway (different stable ID); same basis
      for a TAS "viral protein processing" annotation.
- id: Reactome:R-HSA-9694656
  title: Spike trimer glycoside chains are extended
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Duplicate Reactome spike glycan-extension reaction (different stable ID); same
      basis for a TAS acetylglucosaminyltransferase MF and ERGIC-membrane location.
- id: file:human/MGAT1/MGAT1-deep-research-falcon.md
  title: FutureHouse Falcon deep-research report for MGAT1
  findings:
  - statement: >-
      Deep-research synthesis: MGAT1/GnT-I is a Golgi type II GT13 glycosyltransferase
      that catalyzes the first committed step of complex/hybrid N-glycan synthesis
      (UDP-GlcNAc to alpha-1,3-Man arm of Man5GlcNAc2; Mn2+-dependent); its many
      developmental/immune/cancer phenotypes are indirect, substrate-mediated
      consequences of altered N-glycans and should not be annotated as direct MGAT1
      functions.
    supporting_text: >-
      A key annotation risk is conflating the pleiotropic consequences of altered
      N-glycan structures on substrate glycoproteins with direct MGAT1 molecular
      activities.
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      FutureHouse Falcon deep-research report. Its core-vs-pleiotropic framing is
      concordant with this review and with GO best practice and is used only to
      anchor the synthesis. Most of its primary citations (huang2015, khoderagha2019,
      vicente2023, blomberg2025, chi2025, zhou2024, tang2023, hall2023) are not in the
      publications cache and were not used as supporting_text; substantive claims are
      cited to UniProt, primary papers in cache, and Reactome. See MGAT1-notes.md
      "Falcon integration" for findings used vs rejected.
core_functions:
- description: >-
    MGAT1 catalyzes the first committed (gatekeeper) step of complex and hybrid
    N-glycan biosynthesis: as a Mn2+-dependent, UDP-GlcNAc-using type II Golgi
    membrane glycosyltransferase (GT13, EC 2.4.1.101), it transfers a single GlcNAc
    in beta-1,2 linkage onto the alpha-1,3-mannose arm of the protein-linked
    Man5GlcNAc2 N-glycan, generating the obligate substrate for downstream
    alpha-mannosidase II trimming and MGAT2/4/5 branching. This activity occurs in
    the medial Golgi and converts oligomannose N-glycans into hybrid and complex
    N-glycans; its loss (e.g. the Lec1 CHO mutant) abolishes all complex N-glycan
    synthesis.
  molecular_function:
    id: GO:0003827
    label: alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity
  directly_involved_in:
  - id: GO:0006487
    label: protein N-linked glycosylation
  locations:
  - id: GO:0000139
    label: Golgi membrane
  substrates:
  - id: CHEBI:57705
    label: UDP-N-acetyl-alpha-D-glucosamine
  supported_by:
  - reference_id: PMID:1702225
    supporting_text: >-
      the medial Golgi transferase that initiates complex N-linked carbohydrate
      formation
  - reference_id: Reactome:R-HSA-964768
    supporting_text: >-
      This is the first committed step in the synthesis of complex and hybrid
      N-glycans
  - reference_id: PMID:20378551
    supporting_text: >-
      the BiFC signal with GnTI was detected only in the Golgi membranes of live cells
- description: >-
    MGAT1 binds a divalent manganese ion as an essential catalytic cofactor; the
    Mn2+ coordinates the UDP-GlcNAc donor in the GT-A-type active site, and chelation
    abolishes GlcNAc-TI activity.
  molecular_function:
    id: GO:0030145
    label: manganese ion binding
  locations:
  - id: GO:0000139
    label: Golgi membrane
  supported_by:
  - reference_id: PMID:1702225
    supporting_text: >-
      full-length cDNA encoding human GlcNAc-TI activity
proposed_new_terms:
- proposed_name: oligomannose to complex N-glycan conversion
  proposed_definition: >-
    The committed step of N-glycan maturation in which a single
    N-acetylglucosamine is added in beta-1,2 linkage to the alpha-1,3-mannose arm of
    an oligomannose (Man5GlcNAc2) protein N-glycan, producing the GlcNAcMan5GlcNAc2
    intermediate that is the obligate substrate for alpha-mannosidase II trimming and
    subsequent branching, thereby initiating hybrid and complex N-glycan biosynthesis.
  justification: >-
    MGAT1 occupies a uniquely defined branch point in N-glycan processing
    (GO:0006491), and existing process terms are either too general
    (protein N-linked glycosylation, N-glycan processing) or describe the whole
    complex-N-glycan biosynthetic pathway rather than the specific committed
    initiating step. A child of GO:0006491 (N-glycan processing) grounded on the
    RHEA:11456 reaction would let MGAT1 and its orthologs be annotated to the precise
    gatekeeper step. This is a candidate term; the existing GO:0006487 annotation is
    retained as the best current process term.
  proposed_parent:
    id: GO:0006491
    label: N-glycan processing
suggested_questions:
- question: >-
    Beyond its medial-Golgi pool, does MGAT1 have a functional role at the ERGIC
    membrane (as modeled in Reactome), and does compartmentalization within the
    secretory pathway regulate the oligomannose-to-complex transition?
- question: >-
    Is the BRI3 (ITM2C) interaction functionally relevant to MGAT1 activity, Golgi
    retention, or turnover, or is it an incidental Y2H/co-IP association?
- question: >-
    The reported lactate-induced "mitochondrial MGAT1" role in regulatory T cells
    diverges from the canonical Golgi model; is there independent evidence for a
    non-Golgi, non-canonical localization or function of MGAT1?
suggested_experiments:
- description: >-
    Quantitative glycomic/glycoproteomic comparison of MGAT1-knockout versus
    wild-type human cells (mass spectrometry of released N-glycans) to confirm the
    expected complete loss of hybrid/complex N-glycans and accumulation of
    Man5GlcNAc2, recapitulating the Lec1 phenotype in a human background.
- description: >-
    In vitro reconstitution of purified human MGAT1 with defined Man5GlcNAc2
    glycopeptide acceptors and UDP-GlcNAc to measure kinetics, strict Mn2+
    dependence (EDTA sensitivity), and arm specificity (alpha-1,3 vs alpha-1,6),
    establishing direct human enzymology rather than relying on ortholog data.
- description: >-
    Tagged-MGAT1 co-localization and proximity-labeling (e.g. APEX/BioID) in live
    cells to map its medial-Golgi multi-enzyme assemblies (with MGAT2, MAN2A2, and
    UDP-GlcNAc transporters) and to test whether the perinuclear/ERGIC pools are
    catalytically engaged.

MGAT1

Gene Description

Proposed New Ontology Terms

oligomannose to complex N-glycan conversion

Existing Annotations Review

Core Functions

MGAT1 binds a divalent manganese ion as an essential catalytic cofactor; the Mn2+ coordinates the UDP-GlcNAc donor in the GT-A-type active site, and chelation abolishes GlcNAc-TI activity.

References

Suggested Questions for Experts

Suggested Experiments

Deep Research

Falcon

Gene Research for GO Annotation Review

Target

UniProt Context

Research Objective

Output Requirements

Comprehensive Literature-Backed Research Report for GO Annotation Review of MGAT1

1. EXECUTIVE SUMMARY

2. MOLECULAR FUNCTION

2.1 Core Biochemical Activity

2.2 Cofactor Requirements and Catalytic Mechanism

2.3 Substrate Specificity

3. BIOLOGICAL PROCESS ROLES

3.1 Core Biological Process: Protein N-Glycosylation

3.2 Well-Supported Developmental and Physiological Processes

3.3 Context-Specific and Substrate-Mediated Processes

4. CELLULAR LOCALIZATION AND COMPLEXES

4.1 Subcellular Localization

4.2 Protein Complexes and Interactions

5. ANNOTATION-RISK ASSESSMENT

5.1 Core Function vs. Pleiotropic Effects

5.2 Distinguishing Direct vs. Indirect Roles

5.3 Over-Extension Risks

6. KEY LITERATURE

SUMMARY RECOMMENDATIONS FOR GO ANNOTATION

📚 Additional Documentation

Notes

MGAT1 (human, P26572) — gene review notes

Identity and core enzymology

Subcellular localization (experimental)

Protein interactions

Physiology / biological process (mostly via substrate glycans — non-core)

Reactome

Annotation strategy summary

Falcon integration (2026-06-21)

📄 View Raw YAML